Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Need to increase your savings fast? Discover proven strategies that can help you boost your savings quickly and effectively.
15,082 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Bitcoin’s billion liquidation wave last week rattled crypto markets as BTC tumbled toward $60,000 and almost $10 bill...
When regulators issue a move like government orders anthropic pull, the shockwaves reach crypto markets and risk mana...
Two heavyweight tech stocks have surged on AI bets, but investors face a stark choice: own NVIDIA stock or Micron sto...
A bipartisan Senate vote blocks a Fed digital currency for four years, reshaping money and housing policy. This artic...
A major fraud case exposed how quickly charitable efforts can be twisted for personal gain. Here are practical, money...
As cloud-native tools reshape how enterprises build and store data, investors must decide between GitLab and MongoDB....
A glossy online romance with a powerful royal figure can feel thrilling—until the bills arrive. This article explains...
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
Ericsson's 2026 earnings trajectory hinges on 5G expansion, services, and software. This guide breaks down what to wa...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...